Bit Origin
BTOG
Mawson Infrastructure
MIGI
Coinbase
COIN
Digihost Technology
DGHI
The9 Ltd
NCTY
US Stock MarketDetailed Quotes
NAVB Navidea Biopharmaceuticals
- 0.000
- 0.0000.00%
15min DelayTrading Mar 7 14:49 ET
20.02KMarket Cap0.00P/E (TTM)
0.000High0.000Low100Volume0.000Open0.000Pre Close0.02Turnover0.00%Turnover Ratio0.00P/E (Static)100.08MShares0.13052wk High-0.01P/B13.57KFloat Cap0.00052wk Low--Dividend TTM67.83MShs Float365.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
Navidea Biopharmaceuticals Key Stats
EPS
According to the latest financial report of Navidea Biopharmaceuticals, the latest earnings per share (TTM) for the company is -0.02. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Navidea Biopharmaceuticals's free cash flow? The latest report shows it as -10.27M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Navidea Biopharmaceuticals shows that the company's current ratio is 0.56, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Navidea Biopharmaceuticals, the quick ratio is 0.49, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Navidea Biopharmaceuticals? The latest ROE figure is -221.61%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Navidea Biopharmaceuticals, the total asset return on investment (ROA) is -32.41%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Navidea Biopharmaceuticals's latest financial report to see how their gross margin is doing - currently at -8.10K%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Navidea Biopharmaceuticals, the net profit margin is -570.92K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.